News Archive

2019

September

Media Release / Sep 18, 2019

Migraine is a billion-dollar headache for Singapore, nationwide study finds

Read More

June

Media Release / Jun 20, 2019

Health Sciences Authority approves Novartis Kisqali®, the first and only CDK4/6 inhibitor that significantly extends life in women with HR+/ HER2- advanced breast cancer

Read More
2018

November

Media Release / Nov 22, 2018

World’s first migraine-specific prevention treatment now available in Singapore as Health Sciences Authority approves Novartis Aimovig®

Read More
Media Release / Nov 08, 2018

New social experiment by Novartis encourages Singaporeans to #StartAskin’ to get clear about psoriasis

Read More

July

Media Release / Jul 16, 2018

Health Sciences Authority approves Novartis Kisqali® for the treatment of Stage IV metastatic breast cancer in postmenopausal women

Read More